Abstract
Although the public health impact of direct-to-consumer (DTC) pharmaceutical advertising remains a subject of great controversy, such promotion is typically understood as a recent phenomenon permitted only by changes infederal regulation of print and broadcast advertising over the past two decades. But today's omnipresent ads are only the most recent chapter in a longer history of DTC pharmaceutical promotion (including the ghostwriting of popular articles, organization of public-relations events, and implicit advertising of products to consumers) stretching back over the twentieth century. We use trade literature and archival materials to examine the continuity of efforts to promote prescription drugs to consumers and to better grapple with the public health significance of contemporary pharmaceutical marketing practices.
Original language | English (US) |
---|---|
Pages (from-to) | 793-803 |
Number of pages | 11 |
Journal | American Journal of Public Health |
Volume | 100 |
Issue number | 5 |
DOIs | |
State | Published - May 1 2010 |
Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Public Health, Environmental and Occupational Health
Cite this
Hidden in plain sight. / Greene, Jeremy; Herzberg, David.
In: American Journal of Public Health, Vol. 100, No. 5, 01.05.2010, p. 793-803.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Hidden in plain sight
AU - Greene, Jeremy
AU - Herzberg, David
PY - 2010/5/1
Y1 - 2010/5/1
N2 - Although the public health impact of direct-to-consumer (DTC) pharmaceutical advertising remains a subject of great controversy, such promotion is typically understood as a recent phenomenon permitted only by changes infederal regulation of print and broadcast advertising over the past two decades. But today's omnipresent ads are only the most recent chapter in a longer history of DTC pharmaceutical promotion (including the ghostwriting of popular articles, organization of public-relations events, and implicit advertising of products to consumers) stretching back over the twentieth century. We use trade literature and archival materials to examine the continuity of efforts to promote prescription drugs to consumers and to better grapple with the public health significance of contemporary pharmaceutical marketing practices.
AB - Although the public health impact of direct-to-consumer (DTC) pharmaceutical advertising remains a subject of great controversy, such promotion is typically understood as a recent phenomenon permitted only by changes infederal regulation of print and broadcast advertising over the past two decades. But today's omnipresent ads are only the most recent chapter in a longer history of DTC pharmaceutical promotion (including the ghostwriting of popular articles, organization of public-relations events, and implicit advertising of products to consumers) stretching back over the twentieth century. We use trade literature and archival materials to examine the continuity of efforts to promote prescription drugs to consumers and to better grapple with the public health significance of contemporary pharmaceutical marketing practices.
UR - http://www.scopus.com/inward/record.url?scp=77951218952&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77951218952&partnerID=8YFLogxK
U2 - 10.2105/AJPH.2009.181255
DO - 10.2105/AJPH.2009.181255
M3 - Article
C2 - 20299640
AN - SCOPUS:77951218952
VL - 100
SP - 793
EP - 803
JO - American Journal of Public Health
JF - American Journal of Public Health
SN - 0090-0036
IS - 5
ER -